2,038 reports of this reaction
1.6% of all AZITHROMYCIN DIHYDRATE reports
#15 most reported adverse reaction
ASTHMA is the #15 most commonly reported adverse reaction for AZITHROMYCIN DIHYDRATE, manufactured by Aurobindo Pharma Limited. There are 2,038 FDA adverse event reports linking AZITHROMYCIN DIHYDRATE to ASTHMA. This represents approximately 1.6% of all 126,693 adverse event reports for this drug.
Patients taking AZITHROMYCIN DIHYDRATE who experience asthma should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ASTHMA is a less commonly reported adverse event for AZITHROMYCIN DIHYDRATE, but still significant enough to appear in the safety profile.
In addition to asthma, the following adverse reactions have been reported for AZITHROMYCIN DIHYDRATE:
The following drugs have also been linked to asthma in FDA adverse event reports:
ASTHMA has been reported as an adverse event in 2,038 FDA reports for AZITHROMYCIN DIHYDRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ASTHMA accounts for approximately 1.6% of all adverse event reports for AZITHROMYCIN DIHYDRATE, making it a notable side effect.
If you experience asthma while taking AZITHROMYCIN DIHYDRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.